MM-470 Exploring Alternative Dosing Regimens of Single-Agent Belantamab Mafodotin on Safety and Efficacy in Patients With Relapsed or Refractory Multiple Myeloma (RRMM): DREAMM-14

Autor:	Malin Hultcrantz, David Kleinman, Pavandeep Ghataorhe, Astrid McKeown, Wei He, Thomas Ling, Roxanne C. Jewell, Julie Byrne, Laurie Eliason, Emma Scott, Joanna Opalinska
Rok vydání:	2022
Předmět:	Cancer Research Oncology Hematology
Zdroj:	Clinical Lymphoma Myeloma and Leukemia. 22:S425
ISSN:	2152-2650
DOI:	10.1016/s2152-2650(22)01627-5
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9307304cd08524d2e3ce52103910c0c9 https://doi.org/10.1016/s2152-2650(22)01627-5 Zobrazit plný text záznamu Full Text from ScienceDirect